Is the beta3-adrenergic receptor a new target for treatment of post-infarct ventricular tachyarrhythmias and prevention of sudden cardiac death?
Fedorov
Vadim V
VV
Lozinsky
Ilya T
IT
D058667:Adrenergic beta-3 Receptor Agonists; D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects*; D009203:Myocardial Infarction / Q000150:complications*; D012307:Risk Factors; D017180:Tachycardia, Ventricular / Q000188:drug therapy* / Q000209:etiology; D013997:Time Factors
D058667:Adrenergic beta-3 Receptor Agonists; D000318:Adrenergic beta-Agonists; D000889:Anti-Arrhythmia Agents